Cargando…
The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
BACKGROUND: Clinical evidence showing the effectiveness of recombinant human soluble thrombomodulin (rhTM) for treating sepsis-induced disseminated intravascular coagulation (DIC) and organ dysfunction (particularly renal injury) is limited because of differences in the inclusion criteria and diseas...
Autores principales: | Akatsuka, Masayuki, Masuda, Yoshiki, Tatsumi, Hiroomi, Sonoda, Tomoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729679/ https://www.ncbi.nlm.nih.gov/pubmed/33308326 http://dx.doi.org/10.1186/s40560-020-00512-w |
Ejemplares similares
-
Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release
por: Akatsuka, Masayuki, et al.
Publicado: (2020) -
Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation
por: Suzuki, Y, et al.
Publicado: (2013) -
Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010) -
Pharmacokinetics of Recombinant Human Soluble Thrombomodulin in Disseminated Intravascular Coagulation Patients with Acute Renal Dysfunction
por: Hayakawa, Mineji, et al.
Publicado: (2017) -
A Suggested Link Between Antithrombin Dose and Rate of Recovery from
Disseminated Intravascular Coagulation in Patients with Severe Organ
Failure
por: Kuroda, Hiromitsu, et al.
Publicado: (2022)